324 related articles for article (PubMed ID: 27706114)
1. Antibodies against antigens related to scleroderma in a cohort of patients with morphea.
Arisi M; Cavazzana I; Cerutti ME; Ferrari F; Carabellese N; Rossi MT; Tincani A; Calzavara-Pinton P; Franceschini F
G Ital Dermatol Venereol; 2018 Aug; 153(4):451-458. PubMed ID: 27706114
[TBL] [Abstract][Full Text] [Related]
2. Morphea in adults and children cohort III: nested case-control study--the clinical significance of autoantibodies in morphea.
Dharamsi JW; Victor S; Aguwa N; Ahn C; Arnett F; Mayes MD; Jacobe H
JAMA Dermatol; 2013 Oct; 149(10):1159-65. PubMed ID: 23925398
[TBL] [Abstract][Full Text] [Related]
3. Antinuclear antibodies in children with localized scleroderma.
Rosenberg AM; Uziel Y; Krafchik BR; Hauta SA; Prokopchuk PA; Silverman ED; Laxer RM
J Rheumatol; 1995 Dec; 22(12):2337-43. PubMed ID: 8835572
[TBL] [Abstract][Full Text] [Related]
4. "Borrelia-associated early-onset morphea": a particular type of scleroderma in childhood and adolescence with high titer antinuclear antibodies? Results of a cohort analysis and presentation of three cases.
Prinz JC; Kutasi Z; Weisenseel P; Pótó L; Battyáni Z; Ruzicka T
J Am Acad Dermatol; 2009 Feb; 60(2):248-55. PubMed ID: 19022534
[TBL] [Abstract][Full Text] [Related]
5. Serum autoantibodies profile and increased levels of circulating intercellular adhesion molecule-1: a reflection of the immunologically mediated systemic vasculopathy in rheumatic diseases?
Kuryliszyn-Moskal A; Klimiuk PA; Sierakowski S
Arch Immunol Ther Exp (Warsz); 2001; 49(6):423-30. PubMed ID: 11814236
[TBL] [Abstract][Full Text] [Related]
6. Antinuclear and anti-single-stranded DNA antibodies in morphea and generalized morphea.
Falanga V; Medsger TA; Reichlin M
Arch Dermatol; 1987 Mar; 123(3):350-3. PubMed ID: 3545090
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of systemic autoimmune rheumatic diseases and clinical significance of ANA profile: data from a tertiary hospital in Shanghai, China.
Yang Z; Ren Y; Liu D; Lin F; Liang Y
APMIS; 2016 Sep; 124(9):805-11. PubMed ID: 27328803
[TBL] [Abstract][Full Text] [Related]
8. Demonstration of interleukin 8 and autoantibodies to interleukin 8 in the serum of patients with systemic sclerosis and related disorders.
Reitamo S; Remitz A; Varga J; Ceska M; Effenberger F; Jimenez S; Uitto J
Arch Dermatol; 1993 Feb; 129(2):189-93. PubMed ID: 8434976
[TBL] [Abstract][Full Text] [Related]
9. Coexistence of morphea and systemic sclerosis.
Soma Y; Tamaki T; Kikuchi K; Abe M; Igarashi A; Takehara K; Ishibashi Y
Dermatology; 1993; 186(2):103-5. PubMed ID: 8428037
[TBL] [Abstract][Full Text] [Related]
10. Anti-DNA topoisomerase IIalpha autoantibodies in localized scleroderma.
Hayakawa I; Hasegawa M; Takehara K; Sato S
Arthritis Rheum; 2004 Jan; 50(1):227-32. PubMed ID: 14730620
[TBL] [Abstract][Full Text] [Related]
11. Autoantibodies against matrix metalloproteinase-1 in patients with localized scleroderma.
Tomimura S; Ogawa F; Iwata Y; Komura K; Hara T; Muroi E; Takenaka M; Shimizu K; Hasegawa M; Fujimoto M; Sato S
J Dermatol Sci; 2008 Oct; 52(1):47-54. PubMed ID: 18565735
[TBL] [Abstract][Full Text] [Related]
12. Autoantibodies to the extracellular matrix microfibrillar protein, fibrillin 1, in patients with localized scleroderma.
Arnett FC; Tan FK; Uziel Y; Laxer RM; Krafchik BR; Antohi S; Bona C
Arthritis Rheum; 1999 Dec; 42(12):2656-9. PubMed ID: 10616014
[TBL] [Abstract][Full Text] [Related]
13. Specific anti-nuclear antibodies in systemic sclerosis patients with and without skin involvement: an extended methodological approach.
Van Praet JT; Van Steendam K; Smith V; De Bruyne G; Mimori T; Bonroy C; Elewaut D; Deforce D; De Keyser F
Rheumatology (Oxford); 2011 Jul; 50(7):1302-9. PubMed ID: 21330340
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and characteristics of anti-single-stranded DNA antibodies in localized scleroderma. Comparison with systemic lupus erythematosus.
Ruffatti A; Peserico A; Rondinone R; Calligaro A; Del Ross T; Ghirardello A; Germino M; Todesco S
Arch Dermatol; 1991 Aug; 127(8):1180-3. PubMed ID: 1863075
[TBL] [Abstract][Full Text] [Related]
15. Autoantibodies in Morphea: An Update.
Khatri S; Torok KS; Mirizio E; Liu C; Astakhova K
Front Immunol; 2019; 10():1487. PubMed ID: 31354701
[TBL] [Abstract][Full Text] [Related]
16. Staining of antinuclear antibodies and antibodies against removable nuclear antigens in connective tissue diseases.
Oliva Menacho JE; Arroyo-Acevedo JL; Oliva-Candela JA; García-Hjarles MA; Domínguez-Huarcaya L
Allergol Immunopathol (Madr); 2020; 48(1):18-25. PubMed ID: 31623944
[TBL] [Abstract][Full Text] [Related]
17. Circulating Fc gamma receptor-specific autoantibodies in localized and systemic scleroderma.
Davis K; Boros P; Keltz M; Unkeless JC; Fleischmajer R
J Am Acad Dermatol; 1995 Oct; 33(4):612-6. PubMed ID: 7673494
[TBL] [Abstract][Full Text] [Related]
18. Presence of anti-eukaryotic initiation factor-2B, anti-RuvBL1/2 and anti-synthetase antibodies in patients with anti-nuclear antibody negative systemic sclerosis.
Pauling JD; Salazar G; Lu H; Betteridge ZE; Assassi S; Mayes MD; McHugh NJ
Rheumatology (Oxford); 2018 Apr; 57(4):712-717. PubMed ID: 29294089
[TBL] [Abstract][Full Text] [Related]
19. Autoantibodies to HMG-17 nucleosomal protein in patients with scleroderma.
Vlachoyiannopoulos PG; Boumba VA; Tzioufas AG; Seferiadis C; Tsolas O; Moutsopoulos HM
J Autoimmun; 1994 Apr; 7(2):193-201. PubMed ID: 8037838
[TBL] [Abstract][Full Text] [Related]
20. Frequency of antinuclear antibodies in mestizo Mexican children with morphea.
Guevara-Gutiérrez E; Yinh-Lao J; García-Gutiérrez P; Tlacuilo-Parra A
Clin Rheumatol; 2010 Sep; 29(9):1055-9. PubMed ID: 20549277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
